News
Lupin today announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States. Loteprednol Etabonate Ophthalmic Suspension, 0.5% is bioequivalent to Lotemax Ophthalmic ...
Lupin announced that it has launched Loteprednol Etabonate Ophthalmic Suspension in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback